Clinical potential of a new HIV protease inhibitor.
Chapman
S
S
Agouron Pharmaceuticals, La Jolla, CA.
Peterkin
J
J
Quart
B
B
Youle
M
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D015658:HIV Infections; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification; D008297:Male; D019888:Nelfinavir; D012367:RNA, Viral / Q000097:blood
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D019888:Nelfinavir